XK
IMGN

Xact Kapitalforvaltning’s Immunogen Inc IMGN Stock Holding History

Xact Kapitalforvaltning’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-24,100
Closed -$65K – 1478
2019
Q1 		$65K Hold
24,100
– – ﹤0.01% 1439
2018
Q4 		$116K Hold
24,100
– – ﹤0.01% 1481
2018
Q3 		$228K Hold
24,100
– – ﹤0.01% 1491
2018
Q2 		$234K Buy
24,100
+5,500
+30% +$58K 0.01% 1494
2018
Q1 		$196K Buy
+18,600
New +$184K ﹤0.01% 1491

Other funds holding IMGN

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Xact Kapitalforvaltning's IMGN Position: Q2 2019 in Review

Xact Kapitalforvaltning sold out of Immunogen Inc (IMGN) in Q2 2019, closing a stake of 24,100 shares — an estimated $65K sold.

Xact Kapitalforvaltning first reported a position in IMGN in Q1 2018 and held it in 5 quarters. The position peaked at $234K in Q2 2018. 192 funds tracked by Wall St. Rank hold IMGN as of Q2 2019.

  • Xact Kapitalforvaltning reported no remaining Immunogen Inc position as of Q2 2019 after selling out during the quarter.
  • Xact Kapitalforvaltning sold 24,100 Immunogen Inc shares in Q2 2019, an estimated $65K.
  • Xact Kapitalforvaltning first reported a position in Immunogen Inc in Q1 2018 and held it in 5 quarters.
  • Xact Kapitalforvaltning's Immunogen Inc position peaked at $234K in Q2 2018.
  • 192 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2019.

Based on Xact Kapitalforvaltning's 13F filing for Q2 2019, filed 12 Jul 2019.